High-dose statin therapy in patients with stable coronary artery disease: treating the right patients based on...

Area of Science:

• Cardiology
• Pharmacology
• Clinical Prediction Modeling

Background:

• Identifying optimal statin therapy intensity for coronary artery disease (CAD) patients is crucial for balancing benefits and harms.
• High-dose statins may offer greater benefits but carry increased risks for some individuals.
• Predicting individual treatment effects is essential for personalized medicine in cardiovascular disease.

Purpose of the Study:

• To develop and validate a predictive model for the incremental treatment effect of high-dose statins in CAD patients.
• To estimate the 5-year absolute risk reduction for major adverse cardiovascular events (MACE) with high-dose vs. usual-dose statins.
• To aid clinicians in selecting patients who would gain the most benefit from aggressive statin therapy.

Main Methods:

• A Cox proportional hazards model was developed using data from the Treating to New Targets (TNT) trial (n=10,001).
• The model incorporated 13 easily measurable clinical predictors.
• External validation was performed using data from the Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) trial (n=8888).

Main Results:

• The model demonstrated adequate goodness-of-fit and calibration in external validation.
• Moderate discrimination was observed (C-statistic: 0.63).
• The model identified subgroups: 11.7% with a predicted number needed to treat (NNT) ≤25 and 41.9% with NNT ≥50, suggesting differential benefit.

Conclusions:

• Individualized prediction of high-dose statin incremental treatment effect is feasible.
• This model enables the selection of CAD patients most likely to benefit from intensified statin therapy.
• Clinical decision-making can be enhanced by incorporating these predictions to optimize patient outcomes.